Precision Medicine in Cholangiocarcinoma: Accurate tools for early detection and identification of PRMT5 as a novel pharmacological target (BileCanMet)

Participants: Coordinator - Matias A Avila. CoPIs - Marcin Krawczyk, Francesca Ratti, Meritxel Huch, Pavel Strnad

Call: TRANSCAN-3 Joint Call (JTC) 2024

Amount: 1,305,000 €

Novel Cancer Therapy: Inducing Double-strand DNA Breaks to Foster Tumour Cell Death, Antigenicity and Immunotherapy Response in New Personalized Models (TITAN)

Participants: Coordinator - Jesus M. Banales; CoPIs - Fernando Cossio, Michela Polidoro, Jean-Charles Nault, Elena Palma

Call: TRANSCAN-3 Joint Call (JTC) 2024

Amount:1,197,300 €

Patient-derived models for the Research and Evaluation of Discovery and Innovation in Combination Therapies for Biliary tract Cancer (PREDICT-BC)

Participants: Coordinator - Anna Saborowski. CoPIs - Arndt Vogel, Oreste Segatto, Gregory Schwartz, Mariano Ponz, Tian Tian

Call: TRANSCAN-3 Joint Call (JTC) 2024

Amount:1,304,000 €

Toward next-generation chimeric antigen receptor therapy for cholangiocarcinoma

Participants: Coordinator - Tian Tian. Team members - Angela Lamarca, Mariano Ponz, Alena Gros, Víctor Moreno García
Funding agency: Fundación AstraZeneca

Call: 8th Young Investigator Awards, 2024 Category: Oncology, Precision Medicine and Immuno-oncology

Amount: 225,000 Euro

BileVision: Detection and Treatment of Bile Cancer through Liquid Biopsy and Discovery of New Therapeutic Targets

Participants: Co-PIs - Marcin Krawczyk, Matias A Avila and Carmen Berasain. Team members - Maria Arechederra, Maite G Fernandez-Barrena
Funding agency: Dr. Rolf M. Schwiete Stiftung, Mannheim, Germany
Reference: 2024-040

Amount: 250,000 Euro